Metastatic Renal Cell Carcinoma in a Supraclavicular Lymph Node with No Known Primary: A Case Report
Young-Rak Choi, Hye-Suk Han, Ok-Jun Lee, Sung-Nam Lim, Mi-Jin Kim, Myeong-Ho Yeon, Hyun-Jung Jeon, Ki Hyeong Lee, Seung Taik Kim
Cancer Res Treat. 2012;44(3):215-218.   Published online 2012 Sep 30     DOI: https://doi.org/10.4143/crt.2012.44.3.215
Citations to this article as recorded by Crossref logo
Extrarenal renal cell carcinoma arising in the kidney proximity but without an identifiable renal primary – an intriguing dilemma: report of three cases and review of the literature
Mehdi Mansoor, Morgan Young‐Speirs, Bing Ren, Geoffrey Gotto, Larissa Merten, Summit Sawhney, Farshid Siadat, Andres M Acosta, Abbas Agaimy, Kiril Trpkov
Histopathology.2022; 81(5): 635.     CrossRef
New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?
Elie Rassy, Pauline Parent, Felix Lefort, Stergios Boussios, Giulia Baciarello, Nicholas Pavlidis
Critical Reviews in Oncology/Hematology.2020; 147: 102882.     CrossRef
Metastatic renal cell carcinoma of unknown primary site. Clinical follow-up
N. A. Ognerubov, T. S. Antipova, G. E. Gumareva
Journal of Modern Oncology.2020; 22(3): 149.     CrossRef
Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature
Anders Overby, Lone Duval, Morten Ladekarl, Britt Elmedal Laursen, Frede Donskov
Clinical Genitourinary Cancer.2019; 17(1): e32.     CrossRef
Central pancreatectomy in portal annular pancreas for metastatic renal cell carcinoma: a case report
Hiroshi Yamaguchi, Yasutoshi Kimura, Minoru Nagayama, Masafumi Imamura, Shingo Tanaka, Makoto Yoshida, Eiji Yoshida, Hiroki Fujino, Takashi Machiki, Koji Miyanishi, Toru Mizuguchi, Junji Kato, Ichiro Takemasa
World Journal of Surgical Oncology.2019;[Epub]     CrossRef
Metastatic renal cell carcinoma with undetectable renal mass presenting as lymphadenopathy
Mohamed Salah Fayaz, Aishah Ebrahim Al-Qaderi, Mustafa Shawki El-Sherify
CEN Case Reports.2017; 6(1): 36.     CrossRef
The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future
Lisanne C. Hamming, Ben J. Slotman, Henk M. W. Verheul, Victor L. Thijssen
Angiogenesis.2017; 20(2): 217.     CrossRef
Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction
Esther A. Kleibeuker, Matthijs A. ten Hooven, Kitty C. Castricum, Richard Honeywell, Arjan W. Griffioen, Henk M. Verheul, Ben J. Slotman, Victor L. Thijssen
Cancer Medicine.2015; 4(7): 1003.     CrossRef
Combining radiotherapy with sunitinib: lessons (to be) learned
Esther A. Kleibeuker, Matthijs A. ten Hooven, Henk M. Verheul, Ben J. Slotman, Victor L. Thijssen
Angiogenesis.2015; 18(4): 385.     CrossRef
Sunitinib
Reactions Weekly.2014; 1494(1): 42.     CrossRef
To combine or not combine: the role of radiotherapy and targeted agents in the treatment for renal cell carcinoma
Christian Weiss, Björn Schulze, Annette Ottinger, Claus Rödel
World Journal of Urology.2014; 32(1): 59.     CrossRef